Mr Moch has served as the president of Euclidean Life Science Advisors, which provides strategic advisory services to life sciences companies, since early 2008. Mr Moch was previously managing director of healthcare investment banking at ThinkEquity Partners and chairman, president and CEO of Alteon, a biotechnology company.
The company has also announced that Casey Fox, BioMedical Enterprises’s (BME) founder, will become chief technology officer and continue to focus his efforts on building BME’s innovative product offerings.
Richard Johnston, chairman of BME and managing member of Camden Partners Holdings, said: “Ken is a proven leader who brings extensive senior management and operational experience to BME, as well as a shared strategic vision to create a leading medical device company.”